FASN and cancer: This observation aligns with SREBP1’s role as a well-known regulator of lipid synthesis, controlling the expression of genes such as acetyl-CoA carboxylase, fatty acid synthase, and stearoyl-CoA desaturase, all of which are critical for cancer-related metabolic reprogramming [28].